MARKET

KDEVF

KDEVF

Karolinska Devel
Grey
0.258
NaN%
Closed 09:30 02/06 EST
OPEN
--
PREV CLOSE
0.258
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.258
52 WEEK LOW
0.258
MARKET CAP
242.78M
P/E (TTM)
-5.9083
1D
5D
1M
3M
1Y
5Y
1D
No Data
About KDEVF
Karolinska Development AB is a Sweden-based investment company. The Company provides capital to biotechnology firms, as well as develops and commercializes biotechnological products. Its activities are involved in a range of areas: oncology, infections and wound healing, women’s health, cardiovascular and hematology, medical equipment, diagnostics, pharmaceutical formulation, as well as implants, among others. The Company’s pharmaceuticals portfolio comprises: AXL1717 for non-small-cell lung carcinoma (NSCLC), APR-246 for ovarian cancer, Sevuparin for malaria, SHACT for pain relief at hysteroscopy and intrauterine device (IUD) insertion, and PC-mAB for acute coronary syndrome (ACS), among others. Furthermore, the Company controls a number of subsidiaries, such as Avaris AB, HBV Thernostica AB, KD Incentive AB, KDev Oncology AB and Limone AB.

Webull offers Karolinska Development AB stock information, including Grey: KDEVF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KDEVF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KDEVF stock methods without spending real money on the virtual paper trading platform.